Metabolic Flux Analysis with 13C-label Tracing

Information

  • Research Project
  • 6832640
  • ApplicationId
    6832640
  • Core Project Number
    R43RR020263
  • Full Project Number
    1R43RR020263-01
  • Serial Number
    20263
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/2004 - 20 years ago
  • Project End Date
    4/30/2005 - 20 years ago
  • Program Officer Name
    SWAIN, AMY L
  • Budget Start Date
    9/1/2004 - 20 years ago
  • Budget End Date
    4/30/2005 - 20 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/30/2004 - 20 years ago
Organizations

Metabolic Flux Analysis with 13C-label Tracing

DESCRIPTION (provided by applicant): Advances in bioinformatics and genome research have generated a rapid expansion in the availability of information at all levels of biological investigation. This informational "revolution" in biotechnology has resulted in-part from high-throughput technologies to sequence genes and proteins, and to determine their expression patterns under a variety of environmental conditions. Of equal importance to these genetic-based studies is the investigation of cell physiology and metabolism, as metabolic function leading to cell growth is the ultimate output of genetic regulation. However, historically these areas have received comparatively less attention from the perspective of developing methods for rapid data gathering and subsequent analysis and interpretation. This proposal is aimed at developing a combined experimental/in silico simulation platform, using metabolic flux data derived from 13C-label tracing experiments and a constraints-based metabolic model, to analyze and interpret cell physiology at a systems level. We will perform 13C-labeling experiments with chemostat-grown E. coil cultures, and develop the necessary algorithms to calculate intracellular fluxes. We will then compare these measured values with predictions made by existing metabolic models, and finally explore the feasibility of utilizing this data to improve the predictive power of the models. The construction of an integrated experimental/modeling platform for E. coil marks the first step towards extending these strategies to generate predictive models of human cell lines for use in disease research and drug development. In subsequent phases of the project, we intend to generalize these procedures so that they can be applied to any organism, and automate the analysis procedures to provide a software package for commercial use.

IC Name
NATIONAL CENTER FOR RESEARCH RESOURCES
  • Activity
    R43
  • Administering IC
    RR
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    157824
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    389
  • Ed Inst. Type
  • Funding ICs
    NCRR:157824\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    GENOMATICA, INC.
  • Organization Department
  • Organization DUNS
    071401090
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    921214740
  • Organization District
    UNITED STATES